(Q53561240)

15 May 2018

title

Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial. (English)

1 reference

15 May 2018

author name string

Jörg Emmrich

1

1 reference

15 May 2018

Sebastian Petermann

2

1 reference

15 May 2018

Dietrich Nowak

3

1 reference

15 May 2018

Ingolf Beutner

4

1 reference

15 May 2018

Peter Brock

5

1 reference

15 May 2018

Reinhard Klingel

6

1 reference

15 May 2018

Patrick Mausfeld-Lafdhiya

7

1 reference

15 May 2018

Stefan Liebe

8

1 reference

15 May 2018

Wolfgang Ramlow

9

1 reference

15 May 2018

publication date

5 April 2007

1 reference

15 May 2018

Digestive Diseases and Sciences

published in

1 reference

15 May 2018

volume

52

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

page(s)

2044-2053

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-006-9696-x

exact match

0 references

cites work

The role of Th1/Th2 polarization in mucosal immunity

1 reference

12 December 2020

Azathioprine: state of the art in inflammatory bowel disease

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis

1 reference

12 December 2020

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

12 December 2020

The immunological and genetic basis of inflammatory bowel disease

1 reference

12 December 2020

Medical therapy for ulcerative colitis 2004.

1 reference

12 December 2020

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

1 reference

12 December 2020

Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression

1 reference

12 December 2020

Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.

1 reference

12 December 2020

Leucocytapheresis for ulcerative colitis

1 reference

12 December 2020

Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate.

1 reference

12 December 2020

Cyclosporin for refractory ulcerative colitis

1 reference

12 December 2020

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

1 reference

12 December 2020

Complications of leukocytapheresis

1 reference

12 December 2020

Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question

1 reference

12 December 2020

Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy

1 reference

12 December 2020

Leukocytapheresis for treatment of IBD

1 reference

12 December 2020

Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease.

1 reference

12 December 2020

Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis

1 reference

12 December 2020

Filter leukapheresis for patients with ulcerative colitis: clinical results and the possible mechanism

1 reference

12 December 2020

Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

1 reference

12 December 2020

Leukocytapheresis for rheumatic disease

1 reference

12 December 2020

Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications

1 reference

12 December 2020

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease

1 reference

12 December 2020

Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease

1 reference

12 December 2020

Egress: a receptor-regulated step in lymphocyte trafficking

1 reference

12 December 2020

10.1007/S10620-006-9696-X

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018